XBiotech Inc.
General ticker "XBIT" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $104.9M (TTM average)
XBiotech Inc. does not follow the US Stock Market performance with the rate: -0.2%.
Estimated limits based on current volatility of 2.4%: low 2.41$, high 2.53$
Factors to consider:
- Total employees count: 92 as of 2024
- Top business risk factors: Regulatory and compliance, Product development risks, Supply chain disruptions, Labor/talent shortage/retention, Market acceptance
- Current price 25.1% below estimated low
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [3.35$, 7.40$]
- 2025-12-31 to 2026-12-31 estimated range: [2.88$, 6.50$]
Financial Metrics affecting the XBIT estimates:
- Positive: with PPE of -3.9 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -20.82 <= 0.33
- Negative: negative Industry operating cash flow (median)
- Positive: Shareholder equity ratio, % of 91.55 > 63.39
- Positive: Inventory ratio change, % of 0 <= 0
- Positive: -4.48 < Investing cash flow per share per price, % of -0.88
- Positive: Industry inventory ratio change (median), % of 0 <= 0
- Negative: negative Net income
- Positive: Interest expense per share per price, % of 0.54 <= 0.79
Short-term XBIT quotes
Long-term XBIT plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $4.01MM | $0.00MM | $0.00MM |
| Operating Expenses | $38.50MM | $37.51MM | $42.47MM |
| Operating Income | $-34.49MM | $-37.51MM | $-42.47MM |
| Non-Operating Income | $0.90MM | $13.20MM | $3.91MM |
| Interest Expense | $0.00MM | $0.00MM | $0.81MM |
| R&D Expense | $31.54MM | $32.85MM | $37.76MM |
| Income(Loss) | $-33.59MM | $-24.31MM | $-38.56MM |
| Taxes | $-0.69MM | $0.24MM | $-0.03MM |
| Profit(Loss)* | $-32.90MM | $-24.56MM | $-38.53MM |
| Stockholders Equity | $240.40MM | $218.85MM | $182.27MM |
| Assets | $246.10MM | $226.62MM | $199.09MM |
| Operating Cash Flow | $-14.82MM | $-18.73MM | $-30.96MM |
| Capital expenditure | $0.58MM | $0.36MM | $1.30MM |
| Investing Cash Flow | $-63.89MM | $61.50MM | $-1.30MM |
| Financing Cash Flow | $0.00MM | $-0.01MM | $10.45MM |
| Earnings Per Share** | $-1.08 | $-0.81 | $-1.26 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.